Our campaign will be closing on October 8.  If you have not considered our technology and the investment opportunity it provides, please do so now - before October 8.

Let me recap where we are and how your investment will be used.  

We have produced a fully human anti-HIV monoclonal antibody that has been tested in 5 international laboratories and shown to neutralize HIV – not only to neutralize HIV but to neutralize all HIV variations found around the world. We now are producing the recombinant form of the antibody which must be prepared as it is the form used in patient application. 
 
We have three labs working with us on this task – STC Biologics, Rapid Novor and NovoGene.  Additionally, as part of our partnership with Serum Institute (www.seruminstitute.com), Serum will be funding the confirmation our findings through one of its labs - all in preparation for moving forward with animal and clinical trials.
 
As an investor, hopefully you can appreciate the potential for success both medically and financially.  Find out more on our website www.bioclonetics.com and we hope you will invest before October 8.

We extend our most sincere thanks and appreciation to our many existing investors.  We will be opening an “investors only” Facebook page to keep you up-to-date on our progress.